We resume the series about the scientific achievements by our INVITE fellows continues with Mathieu Repellin, who has been working on nanomedicine solutions to treat Myotonic Dystrophy type 1 .
We resume the series about the scientific achievements by our INVITE fellows continues with Mathieu Repellin, who has been working on nanomedicine solutions to treat Myotonic Dystrophy type 1 .